Crispr Therapeutics shares owned by Caption Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Caption Management
from 13F filings
Historical chart of Caption Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Crispr Therapeutics by Caption Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $35M | 544k | 64.81 |
| 2025-06-30 | $13M | 263k | 48.64 |
| 2025-03-31 | $6.0M | 177k | 34.03 |
| 2024-12-31 | $10M | 255k | 39.36 |
| 2024-09-30 | $28k | 600 | 46.98 |
| 2024-06-30 | $12M | 214k | 54.01 |
| 2024-03-31 | $46M | 680k | 68.16 |
| 2023-12-31 | $61M | 981k | 62.60 |
| 2023-09-30 | $5.8M | 127k | 45.39 |
| 2023-06-30 | $19M | 330k | 56.14 |
| 2022-12-31 | $1.0M | 25k | 40.65 |
| 2022-09-30 | $4.2M | 65k | 65.35 |
| 2022-06-30 | $4.9M | 80k | 60.77 |
| 2022-03-31 | $2.5M | 40k | 62.80 |
| 2021-12-31 | $3.3M | 44k | 75.80 |
| 2021-06-30 | $13M | 82k | 161.90 |
| 2021-03-31 | $5.2M | 43k | 121.86 |
| 2020-06-30 | $13M | 175k | 73.51 |
| 2020-03-31 | $4.2M | 100k | 42.41 |
| 2019-12-31 | $6.1M | 100k | 60.91 |
| 2018-09-30 | $639k | 14k | 44.36 |
| 2018-06-30 | $847k | 14k | 58.83 |